Back to results
CompletedPhase 3

A Study of Semagacestat for Alzheimer's Patients

NCT01035138

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Phoenix, Arizona, United States

+70 additional locations

View on ClinicalTrials.gov
A Study of Semagacestat for Alzheimer's Patients — TrialFind